119 related articles for article (PubMed ID: 12823747)
21. Impact of mobilized blood progenitor cell quality determined by the CFU-GM/CD34+ ratio on rapid engraftment after blood stem cell transplantation.
Fu SQ; Abboud CN; Brennan JK; Ifthikharuddin JJ; Nichols D; Liesveld JL
Blood Cells Mol Dis; 2002; 28(3):315-21. PubMed ID: 12367578
[TBL] [Abstract][Full Text] [Related]
22. CFU-Mk content of immunoselected CD34+ peripheral blood progenitor cells, evaluated with an adapted serum-free methylcellulose assay, is predictive of platelet lineage reconstitution in children with solid tumors.
Boiret N; Kanold J; Fouassier M; Bons JM; Halle P; Rapatel C; Berger J; Pireyre P; Blanzat V; Travade P; Bonhomme J; Demeocq F; Berger MG
J Hematother Stem Cell Res; 2000 Aug; 9(4):525-34. PubMed ID: 10982252
[TBL] [Abstract][Full Text] [Related]
23. Long-term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: effect of the CD34+ cell dose.
Diaz MA; Vicent MG; Garcia-Sanchez F; Vicario JL; Madero L
Vox Sang; 2000; 79(3):145-50. PubMed ID: 11111232
[TBL] [Abstract][Full Text] [Related]
24. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells.
Beguin Y; Baudoux E; Sautois B; Fraipont V; Schaaf-Lafontaine N; Pereira M; Paulus JM; Sondag D; Fillet G
Transfusion; 1998 Feb; 38(2):199-208. PubMed ID: 9531955
[TBL] [Abstract][Full Text] [Related]
26. CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Papadopoulos KP; Ayello J; Reiss RF; Troxel A; Kaufman E; Vahdat LT; Antman KH; Hesdorffer CS
J Hematother Stem Cell Res; 1999 Aug; 8(4):357-63. PubMed ID: 10634173
[TBL] [Abstract][Full Text] [Related]
27. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Hicks C; Wong R; Manoharan A; Kwan YL
Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
[TBL] [Abstract][Full Text] [Related]
28. Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes.
Desoutter J; Ossart C; Lacassagne MN; Regnier A; Marolleau JP; Harrivel V
Cytotherapy; 2019 Jun; 21(6):612-618. PubMed ID: 31056424
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation.
Cancelas JA; Querol S; Canals C; Picón M; Azqueta C; Solà C; Montes A; Amill B; Griera E; Inglés J; López JJ; Germà JR; García-López J
Transfusion; 1998; 38(11-12):1063-70. PubMed ID: 9838939
[TBL] [Abstract][Full Text] [Related]
30. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg.
Abrahamsen JF; Wentzel-Larsen T; Bruserud O
Cytotherapy; 2004; 6(4):356-62. PubMed ID: 16146888
[TBL] [Abstract][Full Text] [Related]
31. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
Han XH; Shi YK; He XH; Yang JL; Liu P
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
[TBL] [Abstract][Full Text] [Related]
32. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
[TBL] [Abstract][Full Text] [Related]
33. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
Faucher C; Le Corroller AG; Chabannon C; Viens P; Stoppa AM; Bouabdallah R; Camerlo J; Vey N; Gravis G; Gastaut JA; Novakovitch G; Mannoni P; Bardou VJ; Moatti JP; Maraninchi D; Blaise D
J Hematother; 1996 Dec; 5(6):663-70. PubMed ID: 9117255
[TBL] [Abstract][Full Text] [Related]
34. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E
Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
[TBL] [Abstract][Full Text] [Related]
35. Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation.
D'Rozario J; Parisotto R; Stapleton J; Gidley A; Owen D
Transfus Apher Sci; 2014 Jun; 50(3):443-50. PubMed ID: 24680293
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
37. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
38. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
39. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
40. Long term hematologic recovery after autologous stem cell transplantation in lymphoma patients: impact of the number of prefreeze and post-thaw CD34+ cells.
Mounier N; Larghero J; Manson J; Brice P; Madelaine-Chambrin I; Brière J; Ertault M; Hennequin C; Miclea JM; Benbunan M; Marolleau JP; Gisselbrecht C
Bull Cancer; 2005 Mar; 92(3):E31-8. PubMed ID: 15820915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
